SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

INCORVAIA, Cristoforo et al. Treating allergic rhinitis by sublingual immunotherapy: a review. Ann. Ist. Super. Sanità [online]. 2012, vol.48, n.2, pp. 172-176. ISSN 0021-2571.  http://dx.doi.org/10.4415/ANN_12_02_10.

    1. Asher MI, Montefort S, Bjorksten B, et al. ISAAc Phase Three Study Group: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAc Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43. http://dx.doi.org/10.1016/S0140-6736(06)69283-0 [ Links ]

    2. Balatsouras DG, Koukoutsis G, Ganelis P, et al. Study of allergic rhinitis in childhood. Int J Otolaryngol, in press, 2011. http://dx.doi.org/10.1155/2011/487532 [ Links ]

    3. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112(Suppl. 6):S118-27. http://dx.doi.org/10.1016/j.jaci.2003.09.033 [ Links ]

    4. Bousquet J, Lockey R, Malling HJ (eds.). Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:58-62. http://dx.doi.org/10.1016/S0091-6749(98)70271-4 [ Links ]

    5. Incorvaia C, Frati F. One century of allergen-specific immunotherapy for respiratory allergy. Immunotherapy 2011;3:629-35. http://dx.doi.org/10.2217/imt.11.36 [ Links ]

    6. Schiappoli M, Ridolo E, Senna G, et al. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin Exp allergy 2009;39(10):1569-74. http://dx.doi.org/10.1111/j.1365-2222.2009.03286.x [ Links ]

    7. Lockey RF, Benedikt LM, Turkeltaub PC, et al. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987;79:660-77. http://dx.doi.org/10.1016/S0091-6749(87)80164-1 [ Links ]

    8. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin allergy 1986:16:483-91. http://dx.doi.org/10.1111/j.1365-2222.1986.tb01983.x [ Links ]

    9. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-48. http://dx.doi.org/10.1067/mai.2003.129 [ Links ]

    10. Bush RK, Swenson C, Fahlberg B, et al. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol 2011;127:984-1. http://dx.doi.org/10.1016/j.jaci.2010.11.045 [ Links ]

    11. Cox L, Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual. Immunol Allergy Clin of North am 2011;31:561-99. http://dx.doi.org/10.1016/j.iac.2011.05.001 [ Links ]

    12. Wilson DR, Torres-Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis: systematic review and metaanalysis. Allergy 2005;60:4-12. http://dx.doi.org/10.1111/j.1398-9995.2005.00699.x [ Links ]

    13. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy. Allergy 2011;66:740-52. http://dx.doi.org/10.1111/j.1398-9995.2011.02583.x [ Links ]

    14. Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig allergol Clin Immunol 2005;15:9-16. [ Links ]

    15. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3-18 years of age: a meta analysis of randomized placebo-controlled, double blind trials. Ann Allergy Asthma Immunol 2006;97:141-8. http://dx.doi.org/10.1016/S1081-1206(10)60004-X [ Links ]

    16. Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009;64:1570-9. http://dx.doi.org/10.1111/j.1398-9995.2009.02129.x [ Links ]

    17. Di Bona D, Plaia A, Scafidi V, et al. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis. J Allergy Clin Immunol 2010;126:558-66. http://dx.doi.org/10.1016/j.jaci.2010.06.013 [ Links ]

    18. Nieto A, Mazon A, Pamies R, et al. Sublingual immunotherapy for allergic respira. tory diseases: an evaluation of meta-analyses. J Allergy Clin Immunol 2009;124:157-61. http://dx.doi.org/10.1016/j.jaci.2009.04.015 [ Links ]

    19. Compalati E, Penagos M, Tarantini F, et al. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol 2009; 102:22-8. http://dx.doi.org/10.1016/S1081-1206(10)60103-2 [ Links ]

    20. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once daily grass allergen tablet: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:802-9. http://dx.doi.org/10.1016/j.jaci.2005.12.1358 [ Links ]

    21. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-45. http://dx.doi.org/10.1016/j.jaci.2007.07.046 [ Links ]

    22. Wahn U, Tabar A, Kuna P, et al. SLIT Study Group: Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160-6. http://dx.doi.org/10.1016/j.jaci.2008.10.009 [ Links ]

    23. Canonica GW, Bousquet J, Casale T, et al. Sublingual immunotherapy: World Allergy Organization Position Paper 2009, Allergy 2009;64(Suppl. 91):1-59. [ Links ]

    24. Devillier P, Brehler R, Sastre J, et al. The clinical development of specific immunotherapies: specific methodological issues and clinical interpretation of results. Allergy 2010;65(Suppl. 92):567-8. [ Links ]

    25. Tahamiler R, Saritzali G, canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope 2007;117:965-9. http://dx.doi.org/10.1097/MLG.0b013e31804f8141 [ Links ]

    26. Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy accordino to its duration: a 15-year prospective study. J Allergy Clin Immunol 2010;126:969-75. http://dx.doi.org/10.1016/j.jaci.2010.08.030 [ Links ]

    27. Andrè C, Vatrinet C, Galvain S. Safety of sublingual swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:220-34. [ Links ]

    28. Di Rienzo V, Minelli M, Musarra A, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp allergy 2005;35:560-4. http://dx.doi.org/10.1111/j.1365-2222.2005.02219.x [ Links ]

    29. Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp allergy 2005;35:565-71. http://dx.doi.org/10.1111/j.1365-2222.2005.02240.x [ Links ]

    30. Passalacqua G, Guerra L, compalati E, et al. The safety of allergen specific sublingual immunotherapy. Curr Drug Saf 2007;2:117-23. http://dx.doi.org/10.2174/157488607780598340 [ Links ]

    31. Frati F, Sensi L, Di Rienzo V, et al. A model for management of sublingual immunotherapy. Eur Ann Allergy Clin Immunol 2003;35:56-60. [ Links ]

    32. André C, Fadel R. Anaphylaxis caused by allergen sublingual immunotherapy? Allergy 2007;62:1220-1. http://dx.doi.org/10.1111/j.1398-9995.2007.01512.x [ Links ]

    33. de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009:64:963-4. http://dx.doi.org/10.1111/j.1398-9995.2009.01998.x [ Links ]

    34. Cochard MM, Eigenmann PA. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy. J Allergy Clin Immunol 2009;124:378-9. http://dx.doi.org/10.1016/j.jaci.2009.04.040 [ Links ]

    35. Incorvaia C, Mauro M. Do indications to sublingual immunotherapy need to be revised? J Allergy Clin Immunol 2010;125:277-8. http://dx.doi.org/10.1016/j.jaci.2009.10.033 [ Links ]

    36. Larsen TH, Poulsen LK, Melac M, et al. Safety and tolerability of grass pollen tablets in sublingual immunotherapy - a phase 1 study. Allergy 2006;61:1173-6. http://dx.doi.org/10.1111/j.1398-9995.2006.01203.x [ Links ]

    37. Berto P, Frati F, Incorvaia C. Economic studies of immunotherapy: a review. Curr Opin Allergy Clin Immunol 2008;8:585-9. [ Links ]

    38. Ciprandi G, Tosca MA, Marseglia GL. Sublingual immunotherapy mechanisms of action: the role of Th1 response. Int J Immunopathol Pharmacol 2009;22(Suppl. 4):9-12. [ Links ]

    39. Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass-pollen induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010;125:131-8. http://dx.doi.org/10.1016/j.jaci.2009.10.035 [ Links ]

    40. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. J Allergy Clin Immunol 2010;104:79-85. http://dx.doi.org/10.1016/j.anai.2009.11.010 [ Links ]

    41. Omnes LF, Bousquet J, Scheinmann P, et al. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France. Eur ann allergy Clin Immunol 2007;39:148-56. [ Links ]

    42. Podladnikova J, Krcmova I, Vlcek J. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 2008;100:482-9. http://dx.doi.org/10.1016/S1081-1206(10)60475-9 [ Links ]

    43. Incorvaia C, Mauro M, Ridolo E, et al. Patient's compliance with allergen immunotherapy. Patient Prefer Adherence 2008;2:247-51. http://dx.doi.org/10.2147/PPA.S3806 [ Links ]